Given the apparent down-regulation of S1PR1 signaling in ASM deficiency, we set to test if reactivation of the S1PR1 pathway in ASM-deficient fibroblasts would rescue the expression of mitochondria-related genes as well as mitochondrial function. The gene discussed is S1PR1; the disease is aggressive systemic mastocytosis.